Le Lézard
Classified in: Health
Subject: ACC

Julphar Announces Q2 2019 Results


"We remain cautious in our outlook but we are confident we are taking the right actions to ensure a full recovery," says company's CEO

RAS AL KHAIMAH, UAE, Aug. 16, 2019 /PRNewswire/ -- Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced its second quarter 2019 financial results.

The company reported Q2 2019 net sales of AED 100 million and a net loss of AED 96m.

Jerome Carle, CEO of Julphar, said: "Firstly, I wish to express my gratitude to our shareholders, our employees, our customers and our partners for their continued support.

"Our second quarter performance was disappointing primarily due to continued challenges in Saudi Arabia coupled with unfavorable conditions in some of our key markets. However, we have started a transformation that will make us stronger in the long run.

"We remain cautious in our outlook but we are confident we are taking the right actions to ensure a full recovery and achieve our long term objectives."  

Julphar's revenue was negatively impacted by the Saudi Food & Drug Authority's temporary ban on the export of the company's products to the Kingdom in September 2018. Consequently, the company's management has focused on cost reductions and has taken several actions to strengthen the organization and maximize cash flows.

Earlier, the Company announced the appointment of new executive employees to help guide the company towards profitability and long-term success.

About Julphar

Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa and for almost four decades, the company has been delivering high quality, innovative and affordable healthcare solutions to families across the globe. Established under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi in 1980, Julphar employs more than 5,000 people and distributes pharmaceutical products to more than 50 countries on five continents.

Julphar's business is centered on three core business units ? Julphar Diabetes Solutions, General Medicines and its consumer division, Julphar Life ? which target major therapeutic segments including Gastrology, Pain Management, Wound Care, Antibiotics and Cardio-metabolism.

Julphar has 16 internationally accredited facilities in Africa, Middle East and Asia that produce more than a million boxes of medicine a day. In 2012, Julphar became one of the largest producers of Insulin with its UAE-based Biotechnology production unit based.

For more information, visit http://www.julphar.net.

Contact:
Chris Goward
[email protected]
+971-(0)58-263-3997

 


These press releases may also interest you

at 12:55
Breckenridge Brewery ("Breckenridge" or the "Brewery"), a pioneer in Colorado's craft beer scene, and a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") , announced today an exciting partnership with the Denver Nuggets to launch a...

at 12:46
Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today a milestone for its iTindtm device with its availability and greater patient access through the largest healthcare group...

at 12:46
Amid the demands of dentistry, where resilience is paramount, practitioners confront challenges beyond clinical skills alone. Thriving in this environment requires a particular mindset, enabling professionals to adeptly navigate pressures, maintain...

at 12:45
The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering. The global smart insulin pens market accounted for USD 0.769 billion in 2023 and is expected to reach at USD 2.30 billion by 2034 with a CAGR of...

at 12:35
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating CNS...

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...



News published on and distributed by: